External Research Program
Evoq Technologies supports ophthalmology, optometry, and vision research professionals in conducting investigator-initiated studies (IIS) using the Twilight™ Dark Adaptometer to test patient adaptation to dark. Through these studies, we aim to validate clinical utility, optimize future deployment strategies, and gather critical real-world evidence.
Objectives
- Assess Twilight’s effectiveness in clinical environments and home-use scenarios.
- Document functional visual performance related to dark adaptation across diverse patient populations.
- Assess clinical and economic value of dark adaptometry in primary eye care practice.
Proposed Research Domains
- Correlation of nyctalopia complaints and measurable dark adaptation dysfunction.
- Dark adaptation as early test and monitoring of diabetic retinopathy.
- Early stage AMD, monitoring treatment and disease progression.
- Occupational screening and safety for night-vision dependent professions.
- Integration into teleophthalmology and remote visual health monitoring.
- Monitoring retinal drug toxicity.
EVOQ Technologies Support
- Depending on the proposed research study and available resources, the company may offer various forms of support. Examples include:
- Availability of the Twilight device for the duration of the study
- Remote technical and clinical support
- Data analytics and publication support
Investigator’s Committments
Investigators are expected to:
- Obtain IRB approval and ensure study compliance with applicable regulations.
- Collect data systematically and ensure rigorous protocol adherence.
- Prepare and submit study outcomes for peer-reviewed publication or conference presentation.
Investigators are encouraged to submit concise study proposals outlining objectives, methodology, patient populations, and intended outcomes by filling out the form below.